Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Current Assets: 2017-2024

Historic Current Assets for Dianthus Therapeutics (DNTH) over the last 6 years, with Dec 2024 value amounting to $280.9 million.

  • Dianthus Therapeutics' Current Assets rose 43.94% to $413.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $413.8 million, marking a year-over-year increase of 43.94%. This contributed to the annual value of $280.9 million for FY2024, which is 58.30% up from last year.
  • As of FY2024, Dianthus Therapeutics' Current Assets stood at $280.9 million, which was up 58.30% from $177.5 million recorded in FY2023.
  • In the past 5 years, Dianthus Therapeutics' Current Assets ranged from a high of $280.9 million in FY2024 and a low of $82.0 million during FY2022.
  • Its 3-year average for Current Assets is $180.1 million, with a median of $177.5 million in 2023.
  • Data for Dianthus Therapeutics' Current Assets shows a peak YoY soared of 116.32% (in 2023) over the last 5 years.
  • Over the past 3 years, Dianthus Therapeutics' Current Assets (Yearly) stood at $82.0 million in 2022, then soared by 116.32% to $177.5 million in 2023, then skyrocketed by 58.30% to $280.9 million in 2024.